DEA Reaffirms Stance That CBD Meets Schedule I Criteria …

  • <!–

    –>
    by Paul Armentano, NORML Deputy Director
    July 10, 2017

    oil_bottlesThe US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … under medical supervision.”

    The agency has long contended that CBD, along with all organic cannabinoids, is — by default — a schedule I controlled substance because it is a naturally occurring component of the cannabis plant. (This position is similarly held by both the NIDA and the FDA.)

    ... read more at: http://blog.norml.org/2017/07/10/dea-reaffirms-stance-that-cbd-meets-schedule-i-criteria-reality-says-otherwise/